A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Diabetes Mellitus and Heart Failure

In brief

This was a dose-finding study to evaluate the efficacy, safety and tolerability of 3 different doses of LIK066 compared to placebo or empagliflozin in T2DM patients with heart failure

Key facts

Study ID

NCT03152552

Run by

Novartis Pharmaceuticals

People needed

125

Starts

2017-07-25

Expected to finish

2018-06-06

Last updated by the study team

2019-08-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Novartis Investigative Site — Carmichael, California, United States
• Novartis Investigative Site — Concord, California, United States
• Novartis Investigative Site — Long Beach, California, United States
• Novartis Investigative Site — Northridge, California, United States
• Novartis Investigative Site — Stockton, California, United States
• Novartis Investigative Site — Colorado Springs, Colorado, United States
• Novartis Investigative Site — Bradenton, Florida, United States
• Novartis Investigative Site — Clearwater, Florida, United States
• Novartis Investigative Site — Delray Beach, Florida, United States
• Novartis Investigative Site — Fort Lauderdale, Florida, United States
• Novartis Investigative Site — Gurnee, Illinois, United States
• Novartis Investigative Site — Bogalusa, Louisiana, United States
• Novartis Investigative Site — Jackson, Mississippi, United States
• Novartis Investigative Site — St Louis, Missouri, United States
• Novartis Investigative Site — Omaha, Nebraska, United States
• Novartis Investigative Site — Charleston, South Carolina, United States
• Novartis Investigative Site — Columbia, South Carolina, United States
• Novartis Investigative Site — San Antonio, Texas, United States
• Novartis Investigative Site — Sugar Land, Texas, United States
• Novartis Investigative Site — Tacoma, Washington, United States
• Novartis Investigative Site — CABA, Buenos Aires, Argentina
• Novartis Investigative Site — CABA, Buenos Aires, Argentina
• Novartis Investigative Site — CABA, Buenos Aires F.D., Argentina
• Novartis Investigative Site — Buenos Aires, Argentina
• Novartis Investigative Site — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.